Clinical trial · Observational
Cost Utility Analysis in Recurrent Ovarian Cancer
Quality of Life and Cost Utility Analysis in the Treatment of Recurrent, Platinum-Resistant Ovarian Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this research study is to learn about the quality of life and sexual functioning of women with platinum-resistant ovarian cancer as they receive other treatments for the disease. Researchers will study the costs for chemotherapy treatments, other medical expenses, and treatment-related expenses that are not medical. Researchers will also review any symptoms these patients may experience related to the cancer or treatment. In addition, researchers want to learn if and how these patients' caregivers feel the status of these patients' health may have affected the caregivers' productivity at work and at home.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Questionnaire
- description
- Longitudinal measure of QOL, sexual functioning and symptoms in women with recurrent, platinum-resistant ovarian cancer receiving multiple second-line treatment regimens
- interventionNames
- Behavioral: Questionnaire
Primary outcomes (1)
- measure
- Mean Score for the FACT-O instrument
- timeFrame
- First 2 days of chemotherapy cycles
- description
- Participants will complete questionnaires 1 - 5 at baseline and Day 1 of each of their chemotherapy cycles.
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: 1. Patients with recurrent, platinum-resistant epithelial ovarian cancer who are beginning any second-line treatment 2. Patients must be English-speaking 3. Patients must be able to read and write English 4. Patients receiving all chemotherapy at MD Anderson Cancer Center Exclusion Criteria: 1. Patients with non-epithelial ovarian cancers including sex-cord stromal tumors, germ cell tumors, low-grade tumors, and metastatic disease to the ovary 2. Patients who are receiving protocol therapy 3. Patients who have had a prior diagnosis of invasive cancer at other sites (excluding basal cell carcinoma of the skin) 4. Patients who are receiving radiation therapy as a treatment modality
References
Publications (0)
Data not yet available